SIGNIFOR LAR Drug Patent Profile
✉ Email this page to a colleague
When do Signifor Lar patents expire, and what generic alternatives are available?
Signifor Lar is a drug marketed by Recordati Rare and is included in one NDA. There are three patents protecting this drug.
The generic ingredient in SIGNIFOR LAR is pasireotide pamoate. One supplier is listed for this compound. Additional details are available on the pasireotide pamoate profile page.
DrugPatentWatch® Generic Entry Outlook for Signifor Lar
Indicators of Generic Entry
Summary for SIGNIFOR LAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Drug Prices: | Drug price information for SIGNIFOR LAR |
What excipients (inactive ingredients) are in SIGNIFOR LAR? | SIGNIFOR LAR excipients list |
DailyMed Link: | SIGNIFOR LAR at DailyMed |
Recent Clinical Trials for SIGNIFOR LAR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Colorado, Denver | Phase 1 |
Hospices Civils de Lyon | Phase 2 |
Zealand University Hospital | Phase 4 |